Literature DB >> 1838039

The fibrinolytic system in diabetes mellitus.

S C Gough1, P J Grant.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1838039     DOI： 10.1111/j.1464-5491.1991.tb01527.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

Review 1.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

2.  Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease.

Authors:  S Inchiostro; G Bertoli; G Zanette; V Donadon
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

3.  Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patients.

Authors: 
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

4.  Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus.

Authors:  M E Britton; A E Denver; V Mohamed-Ali; J S Yudkin
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 3.580

Review 5.  The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation.

Authors:  Albino Carrizzo; Carmine Izzo; Marco Oliveti; Antonia Alfano; Nicola Virtuoso; Mario Capunzo; Paola Di Pietro; Mariaconsiglia Calabrese; Eros De Simone; Sebastiano Sciarretta; Giacomo Frati; Serena Migliarino; Antonio Damato; Mariateresa Ambrosio; Francesco De Caro; Carmine Vecchione
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.